The uncertain role of thrombolytic therapy in the treatment of pulmonary embolism

Archives of Internal Medicine

Volumn 162, Issue 22, 2002, Pages 2521-2523

  Dalen, James E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; UROKINASE;

ACUTE HEART INFARCTION; AGE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG APPROVAL; ECHOCARDIOGRAPHY; EDITORIAL; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FOLLOW UP; FRANCE; GERMANY; HEALTH CARE COST; HEART VENTRICLE FUNCTION; HUMAN; INCIDENCE; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; SHOCK; SURVIVAL; SYMPTOM; THROMBUS; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; MALE; PROGNOSIS; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0037049355     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.22.2521     Document Type: Editorial

References (31)

1. Browse NL, Brist MD, James DCO. Streptokinase and pulmonary embolism. Lancet. 1964;1:1039-1043.
2. Urokinase Pulmonary Embolism Trial: Phase I results. JAMA. 1970;214:2163-2172.
3. Urokinase-Streptokinase Embolism Trial: Phase 2 results. JAMA. 1974;229:1606-1613.
4. Bounameaux H, Vermylen J, Collen D. Thrombolytic treatment with recombinant tissue-type plasminogen activator in a patient with massive pulmonary embolism. Ann Intern Med. 1985;103:64-66.
5. Dalen JE, Alpert JS, Hirsh J. Thrombolytic therapy for pulmonary embolism: Is it effective? Is it safe? When is it indicated? Arch Intern Med. 1997;157:2550-2556.
6. Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: A clinical outcome-based meta-analysis. Arch Intern Med. 2002;162:2537-2541.
7. Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis. 1995;2:227-229.
8. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: Randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507-511.
9. Levine M, Hirsh J, Weitz J, et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest. 1990;98:1473-1479.
10. Dalla-Volta S, Palla A, Santoclincandro A, et al. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. J Am Coll Cardiol. 1992;20:520-526.
11. PIOPED Investigators. Tissue plasminogen activator for the treatment of acute pulmonary embolism. Chest. 1990;97:528-533.
12. Tibbutt DA, Davies JA, Anderson JA, et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. BMJ. 1974;1:343-347.
13. Ly B, Arnesen H, Eie H, et al. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand. 1978;203:465-470.
14. Marini C, Di Ricco G, Rossi R, et al. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: A randomized clinical trial. Respiration. 1988;54:162-173.
15. Goldhaber SZ. Unsolved issues in the treatment of pulmonary embolism. Thromb Res. 2001;103:245-255.
16. Konstantinides S, Geibel A, Kasper W. Submissive and massive pulmonary embolism: A target for thrombolytic therapy? Thromb Haemost. 1999;82(suppl 1):104-108.
17. Hamel E, Pacouret G, Casset-Senon D, et al. Comparative efficacy and risk of low molecular weight heparins and thrombolysis in massive pulmonary embolism without cardiogenic shock [in French]. Arch Mal Coeur Vaiss. 1998;91:295-299.
18. Levine MN. Thrombolytic therapy for venous thromboembolism. Clin Chest Med. 1995;16:321-328.
19. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386-1389.
20. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001;119:176S-193S.
21. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326:1240-1245.
22. Douketis JD, Kearon C, Bates S, et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279:458-462.
23. Cannon CP, Goldhaber SZ. Cardiovascular risk stratification of pulmonary embolism. Am J Cardiol. 1996;78:1149-1151.
24. Sanson BJ, Buller H. Is there a role for thrombolytic therapy in venous thromboembolism? Haemostasis. 1999;29(suppl S1):81-83.
25. Hamel E, Pacouret G, Vincentelli D, et al. Thrombolysis or heparin in massive pulmonary embolism with right ventricular dilation. Chest. 2001;120:120-125.
26. Arasoy S, Kreit JW. Thrombolytic therapy of pulmonary embolism. Chest. 1999;115:1695-1707.
27. Davidson BL, Lensing AWA. Should echocardiography of the right ventricle help determine who receives thrombolysis for pulmonary embolism? Chest. 2001;120:6-8.
28. Konstantinides S, Geibel A, Olschewski M, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Circulation. 1997;96:882-888.
29. Ribeiro A, Lindmarker P, Juhlin-Dannfeit A, et al. Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate. Am Heart J. 1997;134:479-487.
30. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2001;101:2817-2822.
31. Viellard-Baron A, Page B, Augarde R, et al. Acute cor pulmonale in massive pulmonary embolism: Incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med. 2001;27:1481-1486.